top of page

【#ARTICLES|#Biomed】 BioXcel Therapeutics Announces FDA Approval of #IGALMI™

對於精神分裂相關疾病困擾提供助益 “There are large numbers of patients who experience agitation associated with schizophrenia and bipolar disorders, and this condition has been a long-standing challenge for healthcare professionals to treat”

多了另一種治療的選擇 “The approval of #IGALMI, a self-administered film with a desirable onset of action, represents a milestone moment. It provides healthcare teams with an innovative tool to help control agitation. As clinicians, we welcome this much-needed new oral treatment option.”


3 views0 comments


bottom of page